Company profile for Tevogen Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tevogen Bio brings together an experienced team of scientists, public health experts, physicians, and life sciences professionals with the goal of advancing global health by investigating the potential of scalable therapies and vaccines. The company’s mission is to leverage its proprietary immunotherapy platform to develop investigational therapies in oncology, viral vaccines and harnessing its targeted T cell therapy to dev...
Tevogen Bio brings together an experienced team of scientists, public health experts, physicians, and life sciences professionals with the goal of advancing global health by investigating the potential of scalable therapies and vaccines. The company’s mission is to leverage its proprietary immunotherapy platform to develop investigational therapies in oncology, viral vaccines and harnessing its targeted T cell therapy to develop investigational products to treat viral infections such as COVID-19 and Influenza. Tevogen’s unique T cell therapy approach is a major scientific breakthrough under development and investigation to treat COVID-19.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Metuchen, New Jersey
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/11/3204264/0/en/Tevogen-CEO-Supports-Local-Law-Enforcement-with-Personal-Contribution-of-230-000-Company-s-Shares-of-Common-Stock.html

GLOBENEWSWIRE
11 Dec 2025

https://www.globenewswire.com/news-release/2025/12/09/3202736/0/en/Tevogen-Celebrates-Board-Member-Dr-Curtis-Patton-Honored-by-Yale-University-for-Distinguished-Career-and-Lasting-Contributions-to-Medical-Education-and-Equity-in-Medicine.html

GLOBENEWSWIRE
09 Dec 2025

https://www.globenewswire.com/news-release/2025/11/05/3181877/0/en/Tevogen-Reports-Major-Clinical-Milestone-Expands-HLA-Coverage-of-its-Investigational-Precision-T-Cell-Therapy-for-Acute-and-Long-COVID.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179710/0/en/Tevogen-Clarifies-Reported-Financials-Highlighting-Strong-Capital-Efficiency-and-Low-Cash-Burn.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176727/0/en/Tevogen-Senior-Management-Engages-with-Business-and-Community-Leaders-and-Highlights-Recent-Progress.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/15/3167452/0/en/Tevogen-Updates-on-TVGN-489-Following-Growing-Long-COVID-Patient-Interest.html

GLOBENEWSWIRE
15 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty